Abstract:Mitochondrial dynamics plays a critical role in maintaining healthy endothelial function, but whether the atherogenic advanced glycation end products (AGEs) can influence mitochondrial dynamics of endothelial cell remains unclear. AGE modified bovine serum albumin (AGE-BSA) was used as AGEs, primary human aortic endothelial cell line was multiplied, and divided into groups incubated with AGEs of different concentrations for different time. The expression of phosphatase and tensin homologue (PTEN)-induced putative kinase 1 (PINK1) was silenced with specific siRNA. Mitochondrial morphology of HAECs in each group was determined with transmission electron microscopy. Real time PCR method was used to detect the mRNA expression levels of mitochondrial dynamics regulatory genes mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), optic atrophy 1 (Opa1), and dynamin-related protein 1 (Drp1) of HAECs, and western blot method was used to detect the protein expression levels of these regulatory genes. Specific antibody was used to block receptor for advanced glycation end products (RAGE). Treatment of different concentrations of AGEs, HAECs presented more granular mitochondrion, indicating AGEs promoted mitochondrial fission of HAECs remarkably. Silencing PINK1 induced mitochondrial fission in HAECs, and AGEs further promoted mitochondrial fragmentation in HAECs of PINK1 silenced. Different concentrations of AGEs down-regulated the mRNA and protein expression of mitochondrial pro-fusional genes Mfn1, Mfn2, Opa1, up-regulated the expression of mitochondrial pro-fissional gene Drp1, and both of the two phosphorylated Drp1 (p-ser-Drp1-616 and p-ser-Drp1-637) were increased. Time-dependent dynamic alterations of the expression levels of Mfn1, Mfn2, Opa1, and Drp1 were also found in HAECs stimulated with AGEs. Blocking RAGE with anti-RAGE inhibited AGEs induced mitochondrial fission and reversed AGEs induced expression changes of mitochondrial regulatory genes Drp1, Mfn1, Mfn2, and Opa1, indicating AGEs induced mitochondrial fission through RAGE in HAECs. In conclusion, AGEs may promote mitochondrial fission of HAECs through its receptor RAGE, silencing PINK1 induces mitochondrial fission, and AGEs further promote mitochondrial fragmentation in HAECs of PINK1 silenced. AGEs up-regulate the expression of mitochondrial pro-fissional gene Drp1 and down-regulate the expression of mitochondrial pro-fusional genes Mfn1, Mfn2, and Opa1 in HAECs.

Advanced glycated end-products inhibit dilation through constitutive endothelial RAGE and Nox1/4 in rat isolated skeletal muscle arteries

Erk And Akt Signaling Pathways Are Involved In Advanced Glycation End Product-Induced Autophagy In Rat Vascular Smooth Muscle Cells

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

The Role of RAGE, MAPK and NF-κB Pathway in the Advanced Glycation End-Products Induced HUVECs Dysfunction

Advanced Glycation End Products Upregulates The Expression Of Connexin43 Via Erk Mapk And Pi3k/Akt Pathways In Human Endothelial Cells

Advanced Glycation End Products Impair K Ca 3.1- and K Ca 2.3-Mediated Vasodilatation Via Oxidative Stress in Rat Mesenteric Arteries

Advanced Glycation End Products Influence Mitochondrial Fusion-Fission Dynamics Through RAGE in Human Aortic Endothelial Cells.

Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2–NF-κB and JNK–AP-1 signaling pathways

Advanced Glycation End Products Accelerate Rat Vascular Calcification Through RAGE/oxidative Stress.

Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function

Role of peroxisome proliferators-activated receptor-gamma in advanced glycation end product-mediated functional loss of voltage-gated potassium channel in rat coronary arteries

Advanced Glycation End Products Inhibit Distal Colon Contraction In Rats Via Protein Kinase C-Dependent Modulation Of Intracellular Calcium

Advanced glycation end products accelerate ischemia/reperfusion injury through receptor of advanced end product/nitrative thioredoxin inactivation in cardiac microvascular endothelial cells.

Advanced glycation end-products decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells

Effects of Pharmacological Inhibitors of NADPH Oxidase on Myogenic Contractility and Evoked Vasoactive Responses in Rat Resistance Arteries

Advanced Glycation End Products Induce Actin Rearrangement and Subsequent Hyperpermeability in Endothelial Cells

Effects of advanced glycation endproducts on uridine diphosphate-induced contraction in rat carotid artery

Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products.

Effect of Advanced Glycation End Products on the Activity of Na~+/H~+ Exchanger 1 of Vascular Smooth Muscle Cell in Rat

[Advanced Glycation End Products and Their Receptors Elevate the Activity of Endothelin-1 in Rat Cavernosum].

Methylglyoxal-Modified Albumin Effects on Endothelial Arginase Enzyme and Vascular Function